R. Chapin

Publications10
h-index1
Citations11
Highly Influential Citations1
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • M. Dorr
  • 63 Publications • 980 Citations
  • D. Guris
  • 23 Publications • 1,162 Citations
  • C. Kelly
  • 447 Publications • 25,422 Citations
  • E. Dubberke
  • 253 Publications • 11,040 Citations
  • Publications
  • Influence
Bezlotoxumab: Could This be the Answer for Clostridium difficile Recurrence?
Objective: To review the pharmacology, pharmacokinetics, efficacy, safety, and place in therapy of bezlotoxumab (BEZ), a novel monoclonal antibody against Clostridium difficile toxin B. Data Sources:… Expand
Restriction-free antimicrobial stewardship initiative targeting fluoroquinolone reduction across a regional health-system
Summary Background Fluoroquinolone (FQ) antibiotics have become a target of many antimicrobial stewardship programmes. Multiple post-marketing warnings from the Food and Drug Administration caution… Expand
Assessment of a Healthcare-Associated Pneumonia (HCAP) Risk Stratification and Empiric Treatment Guideline: A New Antimicrobial Stewardship Initiative
Abstract Background Risk stratification of HCAP patients is a possible Antimicrobial Stewardship (AST) intervention for the treatment of multidrug resistant (MDR) Gram-negative (GN) vs.… Expand
Epoetin alfa: patient management issues and development through recombinant DNA technology. Part 2: Answers to questions about Epoetin alfa.
1092. Impact of Relieving Infectious Diseases Fellows from Off-Hour/Weekend Antimicrobial Stewardship Coverage
Abstract Background Antimicrobial stewardship programs (ASPs) often utilize Infectious Diseases fellows (IDFs) to cover pre-authorization processes during evening and weekend hours. IDFs often… Expand
228. Fluoroquinolone Prescribing for Diabetic Foot Infections following an FDA Drug Safety Communication for Aortic Aneurysm Risk
54. Microbiologic Characterization and Antibacterial Use in Hospitalized Adults with covid-19 Infection
Background: Coronavirus disease 2019 (CoVID-19) admissions, oft complicated by an uncertain trajectory, lent to treatment influenced by supposition Respiratory bacterial co-infection frequently was… Expand
Grading the Impact of a Standardized Β Lactam Antibiotic Allergy Assessment Protocol for Treatment Decisions: An Antimicrobial Stewardship Target
Abstract Background Approximately 30% of patients at our institution have β-lactam (BL) antibiotic allergies documented in their medical record. This translates to high use of non-β-lactams (NBL) or… Expand
1329. Vancomycin Therapeutic Drug Monitoring: How to hit the Curve
215. Unintended Consequences of Fluoroquinolone Stewardship: Impact on Overall Antimicrobial Use Data and Implications for Benchmarking
Abstract Background Antimicrobial stewardship (AS) initiative to reduce fluoroquinolone (FQ) use in targeted diagnosis-related groups (DRG) across 14 acute care hospitals was launched in 2016 due to… Expand